Physician

Ahila Subramanian, M.D., M.P.H.

According to 2025 Medicare claims, Ahila Subramanian, M.D., M.P.H. (NPI: 1447456413) practices allergy/immunology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44136-9302. Subramanian is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Subramanian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 54 traditional Medicare patients, billed 107 HCPCS/CPT codes, and received $6,889 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 446 prescription claims across 82 beneficiaries totaling $194,648 in drug costs, led by Hyqvia (Igg/Hyaluronidase,recombinant). DME data shows 78 claims. Open Payments data shows 1 records totaling $97. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $11,796 to $6,889. In contrast, Part D prescription costs have risen steadily, from $43,941 to $194,648. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $1,874 and ending at $1,236.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	119	170	$11,796
2016	113	154	$10,100
2017	90	119	$7,732
2018	88	128	$8,901
2019	68	126	$8,218
2020	53	87	$4,414
2021	32	43	$2,952
2022	38	50	$3,948
2023	35	67	$5,267
2024	54	107	$6,889

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	597	$43,941
2016	102	658	$118,076
2017	84	497	$162,188
2018	92	561	$174,344
2019	97	616	$175,223
2020	96	596	$384,051
2021	68	457	$361,579
2022	63	357	$182,392
2023	75	437	$212,678
2024	82	446	$194,648

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	39	$68,733
2017	N/R	N/R	N/R
2018	N/R	12	$66
2019	N/R	12	$28,033
2020	N/R	84	$61,751
2021	N/R	73	$64,291
2022	N/R	N/R	N/R
2023	N/R	67	$127,609
2024	N/R	78	$168,951

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	19	19	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	38	55	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	21	24	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hyqvia	Igg/Hyaluronidase,recombinant	22	616	$69,914
Xolair	Omalizumab	17	476	$39,416
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	15	420	$36,844
Dulera	Mometasone/Formoterol	12	600	$7,385
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	360	$6,631

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	26	$84,554
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	13	$83,246
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	13	$949
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	26	$202

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$97	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahila Subramanian, M.D., M.P.H.?

Tedicare shows public-source Medicare data for Ahila Subramanian, M.D., M.P.H. (NPI 1447456413), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahila Subramanian, M.D., M.P.H. have ACO affiliation data?

Ahila Subramanian, M.D., M.P.H. is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Ahila Subramanian, M.D., M.P.H.?

Ahila Subramanian, M.D., M.P.H. is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Ahila Subramanian, M.D., M.P.H. have Open Payments data?

Ahila Subramanian, M.D., M.P.H. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.